Logo

PerkinElmer's Prenatal Screening Subsidiary Moves to Larger Facility on Long Island

Oct 22, 2008
NEW YORK (GenomeWeb News) – PerkinElmer said on Tuesday that its prenatal screening subsidiary NTD Laboratories has relocated to a new 22,000-square-foot facility in Melville, NY.
 
PerkinElmer said that NTD moved to the new facility from its previous location in Huntington Station, NY, to meet increasing demand for prenatal screening, including tests for Down syndrome, trisomy 18/13, and open neural tube defects, among others.
 
The facility, which PerkinElmer said has been certified by the New York Department of Health, will serve as NTD’s new headquarters. It will use an IT system based on the company's Specimen Gate LIMS, and it will house a maternal sample bank.

Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.